Prospective randomised trial of tubeless vs conventional percutaneous nephrolithotomy (PCNL)
Completed
- Conditions
- Surgery: RenalSurgeryRenal
- Registration Number
- ISRCTN67807054
- Lead Sponsor
- Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 230
Inclusion Criteria
Adults with small-moderate size pelvicalyceal stones.
Exclusion Criteria
Patients with complete stones, solitary functioning kidney, renal insufficiency
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms underlying tubeless percutaneous nephrolithotomy compared to conventional PCNL?
How does tubeless PCNL compare to standard-of-care conventional PCNL in terms of clinical outcomes and recovery time?
Are there specific biomarkers that predict optimal patient selection for tubeless versus conventional PCNL procedures?
What are the known adverse events associated with tubeless PCNL and how do they differ from conventional PCNL?
What are the potential advantages of tubeless PCNL over conventional PCNL in the context of renal surgery innovations?